Suppr超能文献

原位肝移植术后胆道狭窄患者经内镜和/或经皮经肝胆道介入治疗的长期疗效。

Long-term outcome of endoscopic and/or percutaneous transhepatic therapy in patients with biliary stricture after orthotopic liver transplantation.

机构信息

Department of Gastroenterology and Hepatology, Technical University of Munich, Munich, Germany.

出版信息

J Gastroenterol. 2009;44(12):1195-202. doi: 10.1007/s00535-009-0123-x. Epub 2009 Sep 9.

Abstract

BACKGROUND

Biliary strictures are a serious complication after liver transplantation. Endoscopic and percutaneous transhepatic procedures have gained an increasing potential for the management of this problem.

OBJECTIVE

Long-term follow-up of endoscopic and/or percutaneous transhepatic therapy of biliary strictures after liver transplantation was evaluated.

PATIENTS AND METHODS

Between January 1996 and December 2007, 47 patients with biliary stricture after liver transplantation were identified by analysing the endoscopic database, hospital charts and cholangiograms. Long-term follow-up was evaluated using cholangiograms, transabdominal ultrasound, laboratory parameters and physical examination.

RESULTS

The type of biliary stricture after liver transplantation was subdivided into anastomotic stricture (n = 29), non-anastomotic stricture (n = 14) and bilioenterostomy stricture (n = 4). Of the patients, 38/47 were treated by endoscopic procedures (ERCP), and 9/47 patients were treated by percutaneous transhepatic procedures (PTBD). In 2 of 47 patients combined approaches (rendezvous technique) were performed. Overall, 23/29 patients in the anastomotic group, 12/14 patients in the non-anastomotic group, and 3/4 patients in the bilioenterostomy group had successfully completed endoscopic and/or percutaneous transhepatic therapy. Biliary drainage could be respectively terminated after median 9 (1-83), 11 (1-89) and 10 (4-14) months.

CONCLUSIONS

Endoscopic as well as percutaneous transhepatic approaches in combination or as monotherapy are effective in the management of anastomotic and non-anastomotic strictures after liver transplantation.

摘要

背景

胆道狭窄是肝移植后的严重并发症。内镜和经皮经肝途径在处理该问题方面具有越来越大的潜力。

目的

评估肝移植后胆道狭窄的内镜和/或经皮经肝治疗的长期随访结果。

患者和方法

通过分析内镜数据库、病历和胆管造影,1996 年 1 月至 2007 年 12 月期间共发现 47 例肝移植后胆道狭窄患者。通过胆管造影、经腹超声、实验室参数和体格检查评估长期随访结果。

结果

肝移植后胆道狭窄的类型分为吻合口狭窄(n = 29)、非吻合口狭窄(n = 14)和胆肠吻合口狭窄(n = 4)。47 例患者中,38 例行内镜治疗(ERCP),9 例行经皮经肝治疗(PTBD)。2 例患者采用联合途径(会师技术)。总体而言,吻合口组 23/29 例、非吻合口组 12/14 例和胆肠吻合口组 3/4 例患者成功完成了内镜和/或经皮经肝治疗。胆道引流分别在中位数 9(1-83)、11(1-89)和 10(4-14)个月后终止。

结论

内镜和经皮经肝途径联合或单独应用在治疗肝移植后吻合口和非吻合口狭窄方面均有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验